UK clears first use of e-consent tech in clinical trial
A drugmaker trialling an autoimmune disease treatment in the UK has been cleared to use electronic informed consent by the National Health Service (NHS).
Archives for August 27, 2015
Hepalink adding biologics CDMO Cytovance in $200m acquisition
API supplier Hepalink will buy Cytovance for $206m (€183m) in a deal the biologics CDMO says will help expedite its expansion plans.
FDA opts for four-letter suffix to distinguish biologics and biosimilars
The US FDA has published long-awaited guidelines on the non-proprietary naming of biological products, but biosimilar makers say adding a random four-letter suffix could needlessly complicate the prescribing system.
Shire to use new suppliers to up production of HAE drug filtered from US plasma
Shire will use contractors to increase production of Cinryze, the half billion dollar-a-year Hereditary Angioedema (HAE) drug it bought with ViroPharma in 2014.
WuXi enters strategic lab testing partnership with HK-based firm
WuXi PharmaTech has signed a strategic partnership deal to provide exclusive laboratory testing services to Hong Kong-headquartered Lee’s Pharmaceutical.